Clinical Trial Update: Optic Neuritis Treatment Trial (ONTT) [Phase 3]

View source ↗

Summary

Clinical trial update for the Optic Neuritis Treatment Trial (ONTT), a Phase 3 NEI-sponsored study comparing high-dose intravenous methylprednisolone followed b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Optic Neuritis

Drugs mentioned

• PREDNISONE (Prednisone)
• SOLU-MEDROL (Methylprednisolone sodium succinate)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Multiple Sclerosis, Optic Neuritis | Phase 3 | Status: UNKNOWN